Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
248.91
+2.54 (1.03%)
Jan 8, 2026, 4:00 PM EST - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $7.22 billion as of January 9, 2026. Its market cap has increased by 56.04% in one year.
Market Cap
7.22B
Enterprise Value
6.36B
1-Year Change
56.04%
Ranking
Category
Stock Price
$248.91
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $7.22B, an increase of 7,711.44%. That is a compound annual growth rate of 69.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 7.14B | -0.07% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.51B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |